Indaptus Therapeutics, Inc.INDP
| Dec 31, 2021 | Dec 31, 2022 |
---|
Cash and cash equivalents | 39 | 10 |
---|
Marketable securities | - | 17 |
---|
Assets held for sale | 148,400 | - |
---|
Prepaid expenses and other current assets | 1 | 811,433 |
---|
Total current assets | 40 | 27 |
---|
Property and equipment, net | 3,800 | 2,019 |
---|
Right-of-use asset | 169,088 | 79,294 |
---|
Other assets | 16,477 | 738,251 |
---|
Total non-current assets | 189,365 | 819,564 |
---|
Total assets | 41 | 28 |
---|
Accounts payable and other current liabilities | 5 | 3 |
---|
Operating lease liability, current portion | 96,465 | 80,494 |
---|
Total current liabilities | 5 | 3 |
---|
Operating lease liability, net of current portion | 72,862 | - |
---|
Total non-current liabilities | 72,862 | - |
---|
Total liabilities | 5 | 3 |
---|
Common stock: $0.01 par value, 200,000,000 shares authorized as of December 31, 2022 and 2021; 8,401,047 and 8,258,597 shares issued and outstanding as of December 31, 2022 and 2021, respectively | 82,586 | 84,011 |
---|
Additional paid in capital | 51 | 54 |
---|
Accumulated deficit | -16 | -30 |
---|
Accumulated other comprehensive income | - | 96,434 |
---|
Total stockholders’ equity | 36 | 25 |
---|
Total liabilities and stockholders’ equity | 41 | 28 |
---|